Neonatal and infantile cholestasis (NIC) can represent the onset of a surgically correctable disease and of a genetic or metabolic disorder worthy of medical treatment. Timely recognition of NIC and identification of the underlying etiology are paramount to improve outcomes. Upon invitation by the Italian National Institute of Health (ISS), an expert working grouped was formed to formulate evidence-based positions on current knowledge about the diagnosis of NIC. A systematic literature search was conducted to collect evidence about epidemiology, etiology, clinical aspects and accuracy of available diagnostic tests in NIC. Evidence was scored using the GRADE system. All recommendations were approved by a panel of experts upon agreement of at least 75% of the members. The final document was approved by all the panel components. This position document summarizes the collected statements and defines the best-evidence diagnostic approach to cholestasis in the first year of life.

Diagnostic approach to neonatal and infantile cholestasis : A position paper by the SIGENP liver disease working group / G. Ranucci, C. Della Corte, D. Alberti, M.P. Bondioni, G. Boroni, P.L. Calvo, M. Cananzi, M. Candusso, M.G. Clemente, L. D'Antiga, I. Degrassi, J. De Ville De Goyet, F. Di Dato, A. Di Giorgio, C.D. Vici, F. Ferrari, P. Francalanci, M. Fuoti, F. Fusaro, P. Gaio, C. Grimaldi, M. Iascone, G. Indolfi, R. Iorio, G. Maggiore, C. Mandato, L. Matarazzo, L. Monti, F. Mosca, G. Nebbia, F. Nuti, G. Paolella, M. Pinon, P. Roggero, M. Sciveres, D. Serranti, M. Spada, P. Vajro, E. Nicastro. - In: DIGESTIVE AND LIVER DISEASE. - ISSN 1590-8658. - 54:1(2022 Jan), pp. 40-53. [10.1016/j.dld.2021.09.011]

Diagnostic approach to neonatal and infantile cholestasis : A position paper by the SIGENP liver disease working group

F. Mosca;
2022-01

Abstract

Neonatal and infantile cholestasis (NIC) can represent the onset of a surgically correctable disease and of a genetic or metabolic disorder worthy of medical treatment. Timely recognition of NIC and identification of the underlying etiology are paramount to improve outcomes. Upon invitation by the Italian National Institute of Health (ISS), an expert working grouped was formed to formulate evidence-based positions on current knowledge about the diagnosis of NIC. A systematic literature search was conducted to collect evidence about epidemiology, etiology, clinical aspects and accuracy of available diagnostic tests in NIC. Evidence was scored using the GRADE system. All recommendations were approved by a panel of experts upon agreement of at least 75% of the members. The final document was approved by all the panel components. This position document summarizes the collected statements and defines the best-evidence diagnostic approach to cholestasis in the first year of life.
Alagille syndrome; Biliary atresia; Diagnosis; Genetic liver disease; Inborn errors of metabolism; Jaundice; Monogenic liver disease; Newborn
Settore MED/38 - Pediatria Generale e Specialistica
20-ott-2021
Article (author)
File in questo prodotto:
File Dimensione Formato  
Ranucci sigenp 2021.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 837.27 kB
Formato Adobe PDF
837.27 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2434/892264
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 4
  • ???jsp.display-item.citation.isi??? 3
social impact